Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital

被引:58
作者
Miranda-Zapico, Ilargi [1 ]
Eraso, Elena [1 ]
Luis Hernandez-Almaraz, Jose [2 ]
Monica Lopez-Soria, Leyre [2 ]
Javier Carrillo-Munoz, Alfonso [3 ]
Manuel Hernandez-Molina, Juan [4 ]
Quindos, Guillermo [1 ]
机构
[1] Univ Pais Vasco Eskual Herriko Unibertsitatea, Lab Micol Med, Dept Inmunol Microbiol & Parasitol, Fac Med & Odontol, Bilbao, Spain
[2] Hosp Univ Cruces, Microbiol Serv, Baracaldo, Spain
[3] ACIA Microbiol, Barcelona, Spain
[4] Hosp Carlos Haya, Microbiol Serv, Malaga, Spain
关键词
antifungal susceptibility; C; bracarensis; glabrata; metapsilosis; nivariensis; orthopsilosis; parapsilosis; Spain; MOLECULAR DIFFERENTIATION; STREAM INFECTIONS; SP-NOV; ORTHOPSILOSIS; METAPSILOSIS; IDENTIFICATION; SURVEILLANCE; VORICONAZOLE; NIVARIENSIS; BRACARENSIS;
D O I
10.1093/jac/dkr298
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: There is scarce information on the clinical relevance and antifungal susceptibility of Candida bracarensis, Candida nivariensis, Candida orthopsilosis and Candida metapsilosis. The objective of this study was to assess the prevalence and in vitro antifungal susceptibility of these cryptic species among 173 blood isolates previously identified as Candida glabrata or Candida parapsilosis at the Hospital of Cruces (Barakaldo, Spain). The survey was extended to 518 clinical isolates from the culture collection of the Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (UPV-EHU; Bilbao, Spain). Methods: In vitro susceptibilities to 5-fluorocytosine, amphotericin B, anidulafungin, caspofungin, fluconazole, itraconazole, micafungin, posaconazole and voriconazole were tested. Results: All isolates of C. glabrata were identified as C. glabrata sensu stricto. Inside the C. parapsilosis complex, 2.4% of isolates from the Hospital of Cruces and 5.8% from the UPV-EHU were C. metapsilosis or C. orthopsilosis. Of 457 isolates, 435 (95.19%) were C. parapsilosis sensu stricto, 11 (2.41%) C. metapsilosis and 11 (2.41%) C. orthopsilosis. Only seven blood isolates were C. metapsilosis (0.44%) or C. orthopsilosis (1.09%). These cryptic species were also isolated from other relevant clinical specimens. Four C. parapsilosis sensu stricto (5.6%) were susceptible dose-dependent, and one was resistant to both fluconazole and voriconazole (1.4%). Moreover, 19 isolates of C. parapsilosis sensu stricto (26.4%) were intermediately susceptible to itraconazole and higher concentrations of echinocandins were needed to inhibit this species. Most C. orthopsilosis and C. metapsilosis were susceptible to all antifungal agents tested, but one otic isolate of C. metapsilosis was resistant to fluconazole and 5-fluorocytosine. Conclusions: C. metapsilosis and C. orthopsilosis are associated with human disease and show a different antifungal susceptibility profile compared with C. parapsilosis sensu stricto.
引用
收藏
页码:2315 / 2322
页数:8
相关论文
共 36 条
[1]   Phenotypic and molecular characterization of Candida nivarzensis sp nov., a possible new opportunistic fungus [J].
Alcoba-Flórez, J ;
Méndez-Alvarez, S ;
Cano, J ;
Guarro, J ;
Pérez-Roth, E ;
Arévalo, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) :4107-4111
[2]   Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait [J].
Asadzadeh, Mohammad ;
Ahmad, Suhail ;
Al-Sweih, Noura ;
Khan, Zia U. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (06) :745-752
[3]   Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents [J].
Borman, Andrew M. ;
Petch, Rebecca ;
Linton, Christopher J. ;
Palmer, Michael D. ;
Bridge, Paul D. ;
Johnson, Elizabeth M. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (03) :933-938
[4]   In Vitro Fungicidal Activities of Echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis Evaluated by Time-Kill Studies [J].
Canton, Emilia ;
Espinel-Ingroff, Ana ;
Peman, Javier ;
del Castillo, Lucas .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) :2194-2197
[5]   BIOTYPE DIVERSITY OF CANDIDA-PARAPSILOSIS AND ITS RELATIONSHIP TO THE CLINICAL SOURCE AND EXPERIMENTAL PATHOGENICITY [J].
CASSONE, A ;
DEBERNARDIS, F ;
PONTIERI, E ;
CARRUBA, G ;
GIRMENIA, C ;
MARTINO, P ;
FERNANDEZRODRIGUEZ, M ;
QUINDOS, G ;
PONTON, J .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :967-975
[6]   Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan [J].
Chen, Yee-Chun ;
Lin, Yu-Hsin ;
Chen, Kuo-Wei ;
Lii, Joanne ;
Teng, Hwa-Jen ;
Li, Shu-Ying .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 68 (03) :284-292
[7]  
Clinical Laboratory Standards Institute, 2008, M27S3 CLSI
[8]   Candida bracarensis sp nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata [J].
Correia, A ;
Sampaio, P ;
James, S ;
Pais, C .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2006, 56 :313-317
[9]   Characterization of Candida parapsilosis complex isolates [J].
de Toro, M. ;
Torres, M. J. ;
Maite, Ruiz ;
Aznar, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (03) :418-424
[10]   Evaluation of the new chromogenic medium candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species [J].
Eraso, Elena ;
Moragues, Maria D. ;
Villar-Vidal, Maria ;
Sahand, Ismail H. ;
Gonzalez-Gomez, Nagore ;
Ponton, Jose ;
Quindos, Guillermo .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (09) :3340-3345